Correlation Between Acrivon Therapeutics, and Inovio Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Inovio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Inovio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Inovio Pharmaceuticals, you can compare the effects of market volatilities on Acrivon Therapeutics, and Inovio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Inovio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Inovio Pharmaceuticals.
Diversification Opportunities for Acrivon Therapeutics, and Inovio Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acrivon and Inovio is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Inovio Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inovio Pharmaceuticals and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Inovio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inovio Pharmaceuticals has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Inovio Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Inovio Pharmaceuticals
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.16 times more return on investment than Inovio Pharmaceuticals. However, Acrivon Therapeutics, is 1.16 times more volatile than Inovio Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Inovio Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 770.00 in Acrivon Therapeutics, Common on September 1, 2024 and sell it today you would lose (12.00) from holding Acrivon Therapeutics, Common or give up 1.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Inovio Pharmaceuticals
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Inovio Pharmaceuticals |
Acrivon Therapeutics, and Inovio Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Inovio Pharmaceuticals
The main advantage of trading using opposite Acrivon Therapeutics, and Inovio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Inovio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will offset losses from the drop in Inovio Pharmaceuticals' long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
| Inovio Pharmaceuticals vs. Novavax | Inovio Pharmaceuticals vs. Vaxart Inc | Inovio Pharmaceuticals vs. Enveric Biosciences | Inovio Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |